nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CYP2D6—Lomustine—brain cancer	0.171	0.569	CbGbCtD
Metoclopramide—CYP2D6—Hydroxyurea—brain cancer	0.13	0.431	CbGbCtD
Metoclopramide—HTR3A—fourth ventricle—brain cancer	0.0673	0.223	CbGeAlD
Metoclopramide—DRD3—telencephalic ventricle—brain cancer	0.0282	0.0932	CbGeAlD
Metoclopramide—HTR3A—cranial nerve—brain cancer	0.024	0.0793	CbGeAlD
Metoclopramide—HTR4—telencephalon—brain cancer	0.0173	0.0574	CbGeAlD
Metoclopramide—HTR4—pituitary gland—brain cancer	0.0141	0.0467	CbGeAlD
Metoclopramide—HTR3A—ganglion—brain cancer	0.0121	0.0401	CbGeAlD
Metoclopramide—DRD2—telencephalic ventricle—brain cancer	0.0119	0.0394	CbGeAlD
Metoclopramide—Hepatotoxicity—Lomustine—brain cancer	0.0104	0.0392	CcSEcCtD
Metoclopramide—Sunitinib—DAPK1—brain cancer	0.00967	0.365	CrCbGaD
Metoclopramide—HTR4—brain—brain cancer	0.00782	0.0259	CbGeAlD
Metoclopramide—DRD2—ganglion—brain cancer	0.00742	0.0246	CbGeAlD
Metoclopramide—Altered state of consciousness—Temozolomide—brain cancer	0.00666	0.0252	CcSEcCtD
Metoclopramide—CYP11B2—endocrine gland—brain cancer	0.00616	0.0204	CbGeAlD
Metoclopramide—CYP11B1—endocrine gland—brain cancer	0.00616	0.0204	CbGeAlD
Metoclopramide—Visual disturbance—Lomustine—brain cancer	0.00614	0.0232	CcSEcCtD
Metoclopramide—Amenorrhoea—Procarbazine—brain cancer	0.00579	0.0219	CcSEcCtD
Metoclopramide—DRD2—hindbrain—brain cancer	0.00563	0.0186	CbGeAlD
Metoclopramide—HTR3A—brainstem—brain cancer	0.00527	0.0174	CbGeAlD
Metoclopramide—Hepatotoxicity—Hydroxyurea—brain cancer	0.0051	0.0192	CcSEcCtD
Metoclopramide—CYP17A1—gonad—brain cancer	0.00498	0.0165	CbGeAlD
Metoclopramide—Sunitinib—ALK—brain cancer	0.00485	0.183	CrCbGaD
Metoclopramide—Procainamide—DNMT1—brain cancer	0.00474	0.179	CrCbGaD
Metoclopramide—CYP17A1—medulla oblongata—brain cancer	0.00469	0.0155	CbGeAlD
Metoclopramide—HTR3A—telencephalon—brain cancer	0.00468	0.0155	CbGeAlD
Metoclopramide—Gynaecomastia—Procarbazine—brain cancer	0.00455	0.0172	CcSEcCtD
Metoclopramide—Amenorrhoea—Hydroxyurea—brain cancer	0.00448	0.0169	CcSEcCtD
Metoclopramide—DRD3—head—brain cancer	0.00421	0.0139	CbGeAlD
Metoclopramide—Hepatotoxicity—Carmustine—brain cancer	0.00412	0.0156	CcSEcCtD
Metoclopramide—Extrapyramidal disorder—Temozolomide—brain cancer	0.00409	0.0154	CcSEcCtD
Metoclopramide—Hepatotoxicity—Temozolomide—brain cancer	0.00398	0.015	CcSEcCtD
Metoclopramide—Sunitinib—PDGFRA—brain cancer	0.00391	0.148	CrCbGaD
Metoclopramide—Visual impairment—Lomustine—brain cancer	0.00388	0.0146	CcSEcCtD
Metoclopramide—DRD3—central nervous system—brain cancer	0.00385	0.0127	CbGeAlD
Metoclopramide—CYP17A1—endocrine gland—brain cancer	0.00376	0.0124	CbGeAlD
Metoclopramide—CYP17A1—head—brain cancer	0.00371	0.0123	CbGeAlD
Metoclopramide—Rash maculo-papular—Hydroxyurea—brain cancer	0.00358	0.0135	CcSEcCtD
Metoclopramide—CHRM1—telencephalon—brain cancer	0.00355	0.0118	CbGeAlD
Metoclopramide—Amenorrhoea—Temozolomide—brain cancer	0.0035	0.0132	CcSEcCtD
Metoclopramide—CYP17A1—central nervous system—brain cancer	0.00339	0.0112	CbGeAlD
Metoclopramide—CYP2D6—hindbrain—brain cancer	0.00338	0.0112	CbGeAlD
Metoclopramide—Cisapride—CYP2C9—brain cancer	0.00334	0.126	CrCbGaD
Metoclopramide—Laryngospasm—Etoposide—brain cancer	0.0033	0.0124	CcSEcCtD
Metoclopramide—DRD2—brainstem—brain cancer	0.00323	0.0107	CbGeAlD
Metoclopramide—Hepatotoxicity—Etoposide—brain cancer	0.00319	0.012	CcSEcCtD
Metoclopramide—Leukopenia—Lomustine—brain cancer	0.00314	0.0118	CcSEcCtD
Metoclopramide—Respiratory failure—Temozolomide—brain cancer	0.00313	0.0118	CcSEcCtD
Metoclopramide—Urinary incontinence—Carmustine—brain cancer	0.00307	0.0116	CcSEcCtD
Metoclopramide—DRD3—brain—brain cancer	0.00305	0.0101	CbGeAlD
Metoclopramide—Urinary incontinence—Temozolomide—brain cancer	0.00297	0.0112	CcSEcCtD
Metoclopramide—Pollakiuria—Procarbazine—brain cancer	0.00295	0.0111	CcSEcCtD
Metoclopramide—HTR3A—head—brain cancer	0.00291	0.00964	CbGeAlD
Metoclopramide—DRD2—telencephalon—brain cancer	0.00286	0.00947	CbGeAlD
Metoclopramide—Gynaecomastia—Carmustine—brain cancer	0.00285	0.0108	CcSEcCtD
Metoclopramide—Drowsiness—Procarbazine—brain cancer	0.00285	0.0107	CcSEcCtD
Metoclopramide—Jaundice—Procarbazine—brain cancer	0.00277	0.0105	CcSEcCtD
Metoclopramide—CYP17A1—brain—brain cancer	0.00269	0.0089	CbGeAlD
Metoclopramide—HTR3A—central nervous system—brain cancer	0.00266	0.0088	CbGeAlD
Metoclopramide—Body temperature increased—Carboplatin—brain cancer	0.00258	0.00975	CcSEcCtD
Metoclopramide—Hallucination—Procarbazine—brain cancer	0.00254	0.0096	CcSEcCtD
Metoclopramide—Flushing—Procarbazine—brain cancer	0.00237	0.00895	CcSEcCtD
Metoclopramide—DRD2—pituitary gland—brain cancer	0.00233	0.00771	CbGeAlD
Metoclopramide—Neutropenia—Hydroxyurea—brain cancer	0.00231	0.00872	CcSEcCtD
Metoclopramide—Body temperature increased—Lomustine—brain cancer	0.00226	0.00853	CcSEcCtD
Metoclopramide—CHRM1—endocrine gland—brain cancer	0.00224	0.00742	CbGeAlD
Metoclopramide—Rash maculo-papular—Etoposide—brain cancer	0.00224	0.00845	CcSEcCtD
Metoclopramide—CHRM1—head—brain cancer	0.00221	0.00732	CbGeAlD
Metoclopramide—Drowsiness—Hydroxyurea—brain cancer	0.0022	0.00831	CcSEcCtD
Metoclopramide—Nervousness—Procarbazine—brain cancer	0.00216	0.00815	CcSEcCtD
Metoclopramide—HTR3A—brain—brain cancer	0.00211	0.00699	CbGeAlD
Metoclopramide—Tremor—Procarbazine—brain cancer	0.00208	0.00787	CcSEcCtD
Metoclopramide—DRD2—midbrain—brain cancer	0.00206	0.0068	CbGeAlD
Metoclopramide—CHRM1—central nervous system—brain cancer	0.00202	0.00669	CbGeAlD
Metoclopramide—Leukopenia—Procarbazine—brain cancer	0.00199	0.00752	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Etoposide—brain cancer	0.00197	0.00744	CcSEcCtD
Metoclopramide—Hallucination—Hydroxyurea—brain cancer	0.00197	0.00743	CcSEcCtD
Metoclopramide—CYP2D6—brainstem—brain cancer	0.00194	0.00641	CbGeAlD
Metoclopramide—Convulsion—Procarbazine—brain cancer	0.00193	0.00727	CcSEcCtD
Metoclopramide—Hypertension—Procarbazine—brain cancer	0.00192	0.00725	CcSEcCtD
Metoclopramide—Anxiety—Procarbazine—brain cancer	0.00189	0.00712	CcSEcCtD
Metoclopramide—Neutropenia—Carmustine—brain cancer	0.00187	0.00705	CcSEcCtD
Metoclopramide—Confusional state—Procarbazine—brain cancer	0.00183	0.00691	CcSEcCtD
Metoclopramide—Oedema—Procarbazine—brain cancer	0.00182	0.00685	CcSEcCtD
Metoclopramide—DRD2—endocrine gland—brain cancer	0.00181	0.00597	CbGeAlD
Metoclopramide—Neutropenia—Temozolomide—brain cancer	0.0018	0.00681	CcSEcCtD
Metoclopramide—Pollakiuria—Temozolomide—brain cancer	0.00178	0.00673	CcSEcCtD
Metoclopramide—DRD2—head—brain cancer	0.00178	0.0059	CbGeAlD
Metoclopramide—Erectile dysfunction—Temozolomide—brain cancer	0.00178	0.00671	CcSEcCtD
Metoclopramide—Depression—Carmustine—brain cancer	0.00178	0.0067	CcSEcCtD
Metoclopramide—Tachycardia—Procarbazine—brain cancer	0.00177	0.00669	CcSEcCtD
Metoclopramide—CYP2D6—telencephalon—brain cancer	0.00172	0.00569	CbGeAlD
Metoclopramide—Depression—Temozolomide—brain cancer	0.00172	0.00648	CcSEcCtD
Metoclopramide—Cardiac arrest—Etoposide—brain cancer	0.0017	0.00641	CcSEcCtD
Metoclopramide—Nausea—Lomustine—brain cancer	0.0017	0.00641	CcSEcCtD
Metoclopramide—Hypotension—Procarbazine—brain cancer	0.0017	0.0064	CcSEcCtD
Metoclopramide—Insomnia—Procarbazine—brain cancer	0.00164	0.0062	CcSEcCtD
Metoclopramide—DRD2—central nervous system—brain cancer	0.00163	0.00538	CbGeAlD
Metoclopramide—Somnolence—Procarbazine—brain cancer	0.00161	0.00609	CcSEcCtD
Metoclopramide—CHRM1—brain—brain cancer	0.0016	0.00531	CbGeAlD
Metoclopramide—Hallucination—Carmustine—brain cancer	0.00159	0.006	CcSEcCtD
Metoclopramide—DRD2—cerebellum—brain cancer	0.00159	0.00526	CbGeAlD
Metoclopramide—Fatigue—Procarbazine—brain cancer	0.00157	0.00591	CcSEcCtD
Metoclopramide—Leukopenia—Hydroxyurea—brain cancer	0.00154	0.00582	CcSEcCtD
Metoclopramide—Visual impairment—Carmustine—brain cancer	0.00154	0.00581	CcSEcCtD
Metoclopramide—Hallucination—Temozolomide—brain cancer	0.00154	0.0058	CcSEcCtD
Metoclopramide—Bronchospasm—Etoposide—brain cancer	0.00152	0.00573	CcSEcCtD
Metoclopramide—Feeling abnormal—Procarbazine—brain cancer	0.0015	0.00565	CcSEcCtD
Metoclopramide—Convulsion—Hydroxyurea—brain cancer	0.00149	0.00563	CcSEcCtD
Metoclopramide—Visual impairment—Temozolomide—brain cancer	0.00149	0.00562	CcSEcCtD
Metoclopramide—Flushing—Carmustine—brain cancer	0.00148	0.0056	CcSEcCtD
Metoclopramide—Neutropenia—Etoposide—brain cancer	0.00144	0.00545	CcSEcCtD
Metoclopramide—Urticaria—Procarbazine—brain cancer	0.00144	0.00544	CcSEcCtD
Metoclopramide—Body temperature increased—Procarbazine—brain cancer	0.00144	0.00542	CcSEcCtD
Metoclopramide—Flushing—Temozolomide—brain cancer	0.00143	0.00541	CcSEcCtD
Metoclopramide—Oedema—Hydroxyurea—brain cancer	0.0014	0.0053	CcSEcCtD
Metoclopramide—Jaundice—Etoposide—brain cancer	0.00134	0.00507	CcSEcCtD
Metoclopramide—Hypersensitivity—Procarbazine—brain cancer	0.00134	0.00505	CcSEcCtD
Metoclopramide—Tremor—Carmustine—brain cancer	0.0013	0.00492	CcSEcCtD
Metoclopramide—Asthenia—Procarbazine—brain cancer	0.0013	0.00492	CcSEcCtD
Metoclopramide—DRD2—brain—brain cancer	0.00129	0.00427	CbGeAlD
Metoclopramide—Agranulocytosis—Etoposide—brain cancer	0.00129	0.00485	CcSEcCtD
Metoclopramide—Agitation—Carmustine—brain cancer	0.00128	0.00483	CcSEcCtD
Metoclopramide—Tremor—Temozolomide—brain cancer	0.00126	0.00476	CcSEcCtD
Metoclopramide—Dyspnoea—Hydroxyurea—brain cancer	0.00125	0.00473	CcSEcCtD
Metoclopramide—Somnolence—Hydroxyurea—brain cancer	0.00125	0.00471	CcSEcCtD
Metoclopramide—Leukopenia—Carmustine—brain cancer	0.00125	0.0047	CcSEcCtD
Metoclopramide—Diarrhoea—Procarbazine—brain cancer	0.00124	0.00469	CcSEcCtD
Metoclopramide—Agitation—Temozolomide—brain cancer	0.00124	0.00466	CcSEcCtD
Metoclopramide—Angioedema—Temozolomide—brain cancer	0.00123	0.00464	CcSEcCtD
Metoclopramide—Fatigue—Hydroxyurea—brain cancer	0.00121	0.00457	CcSEcCtD
Metoclopramide—Convulsion—Carmustine—brain cancer	0.00121	0.00455	CcSEcCtD
Metoclopramide—Leukopenia—Temozolomide—brain cancer	0.0012	0.00454	CcSEcCtD
Metoclopramide—Hypertension—Carmustine—brain cancer	0.0012	0.00454	CcSEcCtD
Metoclopramide—Dizziness—Procarbazine—brain cancer	0.0012	0.00453	CcSEcCtD
Metoclopramide—Palpitations—Temozolomide—brain cancer	0.00119	0.00449	CcSEcCtD
Metoclopramide—Anxiety—Carmustine—brain cancer	0.00118	0.00446	CcSEcCtD
Metoclopramide—Convulsion—Temozolomide—brain cancer	0.00117	0.0044	CcSEcCtD
Metoclopramide—Hypertension—Temozolomide—brain cancer	0.00116	0.00438	CcSEcCtD
Metoclopramide—Feeling abnormal—Hydroxyurea—brain cancer	0.00116	0.00437	CcSEcCtD
Metoclopramide—Flushing—Etoposide—brain cancer	0.00115	0.00433	CcSEcCtD
Metoclopramide—Confusional state—Carmustine—brain cancer	0.00115	0.00432	CcSEcCtD
Metoclopramide—Rash—Procarbazine—brain cancer	0.00114	0.00432	CcSEcCtD
Metoclopramide—Dermatitis—Procarbazine—brain cancer	0.00114	0.00432	CcSEcCtD
Metoclopramide—Anxiety—Temozolomide—brain cancer	0.00114	0.00431	CcSEcCtD
Metoclopramide—Headache—Procarbazine—brain cancer	0.00114	0.00429	CcSEcCtD
Metoclopramide—Oedema—Carmustine—brain cancer	0.00114	0.00429	CcSEcCtD
Metoclopramide—Body temperature increased—Hydroxyurea—brain cancer	0.00111	0.00419	CcSEcCtD
Metoclopramide—Tachycardia—Carmustine—brain cancer	0.00111	0.00418	CcSEcCtD
Metoclopramide—Confusional state—Temozolomide—brain cancer	0.00111	0.00418	CcSEcCtD
Metoclopramide—Oedema—Temozolomide—brain cancer	0.0011	0.00414	CcSEcCtD
Metoclopramide—CYP2D6—endocrine gland—brain cancer	0.00108	0.00359	CbGeAlD
Metoclopramide—Nausea—Procarbazine—brain cancer	0.00108	0.00407	CcSEcCtD
Metoclopramide—CYP2D6—head—brain cancer	0.00107	0.00354	CbGeAlD
Metoclopramide—Hypotension—Carmustine—brain cancer	0.00106	0.00401	CcSEcCtD
Metoclopramide—Hypersensitivity—Hydroxyurea—brain cancer	0.00104	0.00391	CcSEcCtD
Metoclopramide—Muscle spasms—Etoposide—brain cancer	0.00103	0.00391	CcSEcCtD
Metoclopramide—Insomnia—Carmustine—brain cancer	0.00103	0.00388	CcSEcCtD
Metoclopramide—Dyspnoea—Carmustine—brain cancer	0.00101	0.00382	CcSEcCtD
Metoclopramide—Somnolence—Carmustine—brain cancer	0.00101	0.00381	CcSEcCtD
Metoclopramide—Asthenia—Hydroxyurea—brain cancer	0.00101	0.0038	CcSEcCtD
Metoclopramide—Insomnia—Temozolomide—brain cancer	0.000993	0.00375	CcSEcCtD
Metoclopramide—Dyspnoea—Temozolomide—brain cancer	0.000979	0.00369	CcSEcCtD
Metoclopramide—CYP2D6—central nervous system—brain cancer	0.000978	0.00324	CbGeAlD
Metoclopramide—Somnolence—Temozolomide—brain cancer	0.000976	0.00368	CcSEcCtD
Metoclopramide—Leukopenia—Etoposide—brain cancer	0.000963	0.00364	CcSEcCtD
Metoclopramide—Diarrhoea—Hydroxyurea—brain cancer	0.000961	0.00363	CcSEcCtD
Metoclopramide—CYP2D6—cerebellum—brain cancer	0.000955	0.00316	CbGeAlD
Metoclopramide—Fatigue—Temozolomide—brain cancer	0.000946	0.00357	CcSEcCtD
Metoclopramide—Feeling abnormal—Carmustine—brain cancer	0.000936	0.00353	CcSEcCtD
Metoclopramide—Convulsion—Etoposide—brain cancer	0.000932	0.00352	CcSEcCtD
Metoclopramide—Hypertension—Etoposide—brain cancer	0.000929	0.00351	CcSEcCtD
Metoclopramide—Dizziness—Hydroxyurea—brain cancer	0.000929	0.00351	CcSEcCtD
Metoclopramide—Feeling abnormal—Temozolomide—brain cancer	0.000904	0.00341	CcSEcCtD
Metoclopramide—Body temperature increased—Carmustine—brain cancer	0.000898	0.00339	CcSEcCtD
Metoclopramide—Rash—Hydroxyurea—brain cancer	0.000886	0.00334	CcSEcCtD
Metoclopramide—Confusional state—Etoposide—brain cancer	0.000886	0.00334	CcSEcCtD
Metoclopramide—Dermatitis—Hydroxyurea—brain cancer	0.000885	0.00334	CcSEcCtD
Metoclopramide—Headache—Hydroxyurea—brain cancer	0.00088	0.00332	CcSEcCtD
Metoclopramide—Urticaria—Temozolomide—brain cancer	0.000872	0.00329	CcSEcCtD
Metoclopramide—Body temperature increased—Temozolomide—brain cancer	0.000868	0.00327	CcSEcCtD
Metoclopramide—Tachycardia—Etoposide—brain cancer	0.000857	0.00324	CcSEcCtD
Metoclopramide—Hypersensitivity—Carmustine—brain cancer	0.000837	0.00316	CcSEcCtD
Metoclopramide—Nausea—Hydroxyurea—brain cancer	0.000835	0.00315	CcSEcCtD
Metoclopramide—Hypotension—Etoposide—brain cancer	0.000821	0.0031	CcSEcCtD
Metoclopramide—Asthenia—Carmustine—brain cancer	0.000815	0.00308	CcSEcCtD
Metoclopramide—Hypersensitivity—Temozolomide—brain cancer	0.000809	0.00305	CcSEcCtD
Metoclopramide—Asthenia—Temozolomide—brain cancer	0.000787	0.00297	CcSEcCtD
Metoclopramide—Dyspnoea—Etoposide—brain cancer	0.000783	0.00296	CcSEcCtD
Metoclopramide—Somnolence—Etoposide—brain cancer	0.000781	0.00295	CcSEcCtD
Metoclopramide—Diarrhoea—Carmustine—brain cancer	0.000777	0.00293	CcSEcCtD
Metoclopramide—CYP2D6—brain—brain cancer	0.000776	0.00257	CbGeAlD
Metoclopramide—Fatigue—Etoposide—brain cancer	0.000757	0.00286	CcSEcCtD
Metoclopramide—Dizziness—Carmustine—brain cancer	0.000751	0.00283	CcSEcCtD
Metoclopramide—Diarrhoea—Temozolomide—brain cancer	0.000751	0.00283	CcSEcCtD
Metoclopramide—Dizziness—Temozolomide—brain cancer	0.000726	0.00274	CcSEcCtD
Metoclopramide—Feeling abnormal—Etoposide—brain cancer	0.000724	0.00273	CcSEcCtD
Metoclopramide—Rash—Carmustine—brain cancer	0.000716	0.0027	CcSEcCtD
Metoclopramide—Dermatitis—Carmustine—brain cancer	0.000715	0.0027	CcSEcCtD
Metoclopramide—Headache—Carmustine—brain cancer	0.000712	0.00269	CcSEcCtD
Metoclopramide—Urticaria—Etoposide—brain cancer	0.000698	0.00263	CcSEcCtD
Metoclopramide—Body temperature increased—Etoposide—brain cancer	0.000694	0.00262	CcSEcCtD
Metoclopramide—Rash—Temozolomide—brain cancer	0.000692	0.00261	CcSEcCtD
Metoclopramide—Dermatitis—Temozolomide—brain cancer	0.000691	0.00261	CcSEcCtD
Metoclopramide—Headache—Temozolomide—brain cancer	0.000688	0.0026	CcSEcCtD
Metoclopramide—Nausea—Carmustine—brain cancer	0.000675	0.00255	CcSEcCtD
Metoclopramide—Nausea—Temozolomide—brain cancer	0.000652	0.00246	CcSEcCtD
Metoclopramide—Hypersensitivity—Etoposide—brain cancer	0.000647	0.00244	CcSEcCtD
Metoclopramide—Asthenia—Etoposide—brain cancer	0.00063	0.00238	CcSEcCtD
Metoclopramide—Diarrhoea—Etoposide—brain cancer	0.000601	0.00227	CcSEcCtD
Metoclopramide—Dizziness—Etoposide—brain cancer	0.000581	0.00219	CcSEcCtD
Metoclopramide—Rash—Etoposide—brain cancer	0.000554	0.00209	CcSEcCtD
Metoclopramide—Dermatitis—Etoposide—brain cancer	0.000553	0.00209	CcSEcCtD
Metoclopramide—Headache—Etoposide—brain cancer	0.00055	0.00208	CcSEcCtD
Metoclopramide—Nausea—Etoposide—brain cancer	0.000522	0.00197	CcSEcCtD
Metoclopramide—CHRM1—GPCR ligand binding—PTCH2—brain cancer	0.000334	0.00317	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—TRPC6—brain cancer	0.000329	0.00312	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000329	0.00312	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—SHH—brain cancer	0.000323	0.00306	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—TRPC6—brain cancer	0.000311	0.00295	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—SMO—brain cancer	0.000306	0.0029	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—PTCH1—brain cancer	0.000306	0.0029	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—OR14C36—brain cancer	0.000299	0.00284	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—OR4C12—brain cancer	0.000299	0.00284	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.000296	0.0028	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CYP2C9—brain cancer	0.000295	0.0028	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000294	0.00279	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—OR4C12—brain cancer	0.000293	0.00278	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—OR14C36—brain cancer	0.000293	0.00278	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ABR—brain cancer	0.000291	0.00275	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.00029	0.00274	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GLI2—brain cancer	0.000281	0.00266	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—SIRT1—brain cancer	0.000277	0.00263	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—OR14C36—brain cancer	0.000272	0.00258	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—OR4C12—brain cancer	0.000272	0.00258	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—OR4C12—brain cancer	0.000266	0.00252	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—OR14C36—brain cancer	0.000266	0.00252	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GLI1—brain cancer	0.000264	0.0025	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—VAV1—brain cancer	0.000257	0.00243	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYP2C9—brain cancer	0.000254	0.00241	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—BSG—brain cancer	0.000251	0.00238	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SUFU—brain cancer	0.00025	0.00237	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.000242	0.00229	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GFAP—brain cancer	0.000241	0.00229	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP2C9—brain cancer	0.000238	0.00225	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—VAV1—brain cancer	0.000233	0.00221	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—SHH—brain cancer	0.00023	0.00218	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PTCH2—brain cancer	0.000229	0.00217	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HEY1—brain cancer	0.000229	0.00217	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—DLL1—brain cancer	0.000224	0.00213	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—PTCH1—brain cancer	0.000218	0.00206	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—SMO—brain cancer	0.000218	0.00206	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—BSG—brain cancer	0.000216	0.00205	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—IDH1—brain cancer	0.000216	0.00204	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—SIRT1—brain cancer	0.000212	0.00201	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OR4C12—brain cancer	0.00021	0.00199	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OR14C36—brain cancer	0.00021	0.00199	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—CDK4—brain cancer	0.00021	0.00199	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—SIRT1—brain cancer	0.000208	0.00197	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—BSG—brain cancer	0.000202	0.00192	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ABR—brain cancer	0.000198	0.00187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SHH—brain cancer	0.000191	0.00181	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—APC—brain cancer	0.000188	0.00178	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.000188	0.00178	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—IDH1—brain cancer	0.000186	0.00176	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TRPC6—brain cancer	0.000184	0.00174	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SMO—brain cancer	0.000181	0.00171	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PTCH1—brain cancer	0.000181	0.00171	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ABR—brain cancer	0.00018	0.0017	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DTX2—brain cancer	0.000178	0.00169	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—SHH—brain cancer	0.000176	0.00167	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000176	0.00167	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PTCH2—brain cancer	0.000175	0.00166	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—IDH1—brain cancer	0.000174	0.00165	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—SHH—brain cancer	0.000172	0.00163	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PTCH2—brain cancer	0.000171	0.00162	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ENO2—brain cancer	0.000171	0.00162	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—PTCH1—brain cancer	0.000167	0.00158	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—SMO—brain cancer	0.000167	0.00158	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—PTCH1—brain cancer	0.000163	0.00155	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—SMO—brain cancer	0.000163	0.00155	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—PIK3CG—brain cancer	0.000163	0.00155	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OR14C36—brain cancer	0.000161	0.00152	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OR4C12—brain cancer	0.000161	0.00152	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—CDK4—brain cancer	0.00016	0.00152	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OR14C36—brain cancer	0.000157	0.00149	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OR4C12—brain cancer	0.000157	0.00149	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—CDK4—brain cancer	0.000157	0.00149	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000151	0.00143	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ABR—brain cancer	0.000151	0.00143	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—PIK3CG—brain cancer	0.000148	0.0014	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ABR—brain cancer	0.000148	0.0014	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ENO2—brain cancer	0.000147	0.00139	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOTCH2—brain cancer	0.000145	0.00137	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000142	0.00134	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VAV1—brain cancer	0.000138	0.00131	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ENO2—brain cancer	0.000138	0.0013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ABR—brain cancer	0.000137	0.0013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DTX2—brain cancer	0.000137	0.00129	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTCH2—brain cancer	0.000135	0.00128	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ABR—brain cancer	0.000135	0.00127	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DTX2—brain cancer	0.000134	0.00127	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HES5—brain cancer	0.000131	0.00124	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STRADA—brain cancer	0.000127	0.0012	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TRPC6—brain cancer	0.000125	0.00119	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HES1—brain cancer	0.000119	0.00112	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—SHH—brain cancer	0.000118	0.00112	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—IL2—brain cancer	0.000115	0.00109	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TRPC6—brain cancer	0.000114	0.00108	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PDGFRA—brain cancer	0.000113	0.00107	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PTCH1—brain cancer	0.000112	0.00106	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—SMO—brain cancer	0.000112	0.00106	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SPP1—brain cancer	0.00011	0.00104	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ABR—brain cancer	0.000106	0.00101	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL2—brain cancer	0.000104	0.000988	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTCH2—brain cancer	0.000103	0.00098	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GLI2—brain cancer	0.000102	0.000971	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTCH2—brain cancer	0.000101	0.00096	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000101	0.000957	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HES5—brain cancer	0.0001	0.00095	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IRS2—brain cancer	9.91e-05	0.000939	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HES5—brain cancer	9.81e-05	0.000929	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STRADA—brain cancer	9.73e-05	0.000922	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GLI1—brain cancer	9.64e-05	0.000913	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TRPC6—brain cancer	9.58e-05	0.000908	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STRADA—brain cancer	9.52e-05	0.000902	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—VAV1—brain cancer	9.38e-05	0.000889	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	9.38e-05	0.000889	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SUFU—brain cancer	9.13e-05	0.000865	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—SHH—brain cancer	9.02e-05	0.000855	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TP53—brain cancer	8.92e-05	0.000845	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—SHH—brain cancer	8.83e-05	0.000837	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GFAP—brain cancer	8.81e-05	0.000835	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PIK3CG—brain cancer	8.75e-05	0.000829	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—APC—brain cancer	8.75e-05	0.000829	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TRPC6—brain cancer	8.7e-05	0.000824	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PTCH1—brain cancer	8.55e-05	0.000811	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—SMO—brain cancer	8.55e-05	0.000811	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—VAV1—brain cancer	8.52e-05	0.000807	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TRPC6—brain cancer	8.52e-05	0.000807	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PTCH1—brain cancer	8.37e-05	0.000793	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—SMO—brain cancer	8.37e-05	0.000793	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HEY1—brain cancer	8.35e-05	0.000792	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DLL1—brain cancer	8.19e-05	0.000776	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ABR—brain cancer	8.12e-05	0.000769	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—EGFR—brain cancer	7.97e-05	0.000755	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ABR—brain cancer	7.95e-05	0.000753	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GLI2—brain cancer	7.84e-05	0.000743	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PIK3CG—brain cancer	7.83e-05	0.000742	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GLI2—brain cancer	7.67e-05	0.000727	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.53e-05	0.000714	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GLI1—brain cancer	7.37e-05	0.000699	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GLI1—brain cancer	7.22e-05	0.000684	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—VAV1—brain cancer	7.18e-05	0.00068	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—VAV1—brain cancer	7.03e-05	0.000666	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SUFU—brain cancer	6.99e-05	0.000662	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SHH—brain cancer	6.97e-05	0.00066	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SUFU—brain cancer	6.84e-05	0.000648	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RELA—brain cancer	6.84e-05	0.000648	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—brain cancer	6.82e-05	0.000646	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ERBB2—brain cancer	6.8e-05	0.000644	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3CG—brain cancer	6.74e-05	0.000639	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GFAP—brain cancer	6.74e-05	0.000639	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TRPC6—brain cancer	6.72e-05	0.000636	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—brain cancer	6.68e-05	0.000633	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTCH1—brain cancer	6.6e-05	0.000626	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SMO—brain cancer	6.6e-05	0.000626	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GFAP—brain cancer	6.6e-05	0.000625	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—VAV1—brain cancer	6.52e-05	0.000618	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2C9—brain cancer	6.43e-05	0.00061	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HEY1—brain cancer	6.39e-05	0.000606	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—VAV1—brain cancer	6.38e-05	0.000605	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CG—brain cancer	6.31e-05	0.000598	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DLL1—brain cancer	6.27e-05	0.000594	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HEY1—brain cancer	6.26e-05	0.000593	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2—brain cancer	6.16e-05	0.000583	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DLL1—brain cancer	6.14e-05	0.000581	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCND1—brain cancer	6e-05	0.000569	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CG—brain cancer	5.96e-05	0.000564	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CTNNB1—brain cancer	5.95e-05	0.000563	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—BSG—brain cancer	5.47e-05	0.000518	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CG—brain cancer	5.41e-05	0.000513	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SHH—brain cancer	5.33e-05	0.000505	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOTCH2—brain cancer	5.28e-05	0.0005	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—brain cancer	5.23e-05	0.000496	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SHH—brain cancer	5.22e-05	0.000494	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—STAT3—brain cancer	5.18e-05	0.000491	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TRPC6—brain cancer	5.14e-05	0.000487	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTCH1—brain cancer	5.05e-05	0.000479	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SMO—brain cancer	5.05e-05	0.000479	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VAV1—brain cancer	5.03e-05	0.000477	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TRPC6—brain cancer	5.03e-05	0.000477	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SMO—brain cancer	4.95e-05	0.000469	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTCH1—brain cancer	4.95e-05	0.000469	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MYC—brain cancer	4.82e-05	0.000456	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EGFR—brain cancer	4.71e-05	0.000446	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—IDH1—brain cancer	4.7e-05	0.000446	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	4.56e-05	0.000432	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	4.46e-05	0.000423	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HES1—brain cancer	4.33e-05	0.00041	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2—brain cancer	4.19e-05	0.000397	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CG—brain cancer	4.14e-05	0.000392	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PDGFRA—brain cancer	4.12e-05	0.000391	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	4.05e-05	0.000384	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOTCH2—brain cancer	4.04e-05	0.000383	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SPP1—brain cancer	4e-05	0.000379	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—brain cancer	3.95e-05	0.000375	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOTCH2—brain cancer	3.95e-05	0.000375	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VAV1—brain cancer	3.85e-05	0.000365	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2—brain cancer	3.81e-05	0.000361	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VAV1—brain cancer	3.77e-05	0.000357	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ENO2—brain cancer	3.72e-05	0.000352	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IRS2—brain cancer	3.62e-05	0.000343	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HES1—brain cancer	3.31e-05	0.000314	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HES1—brain cancer	3.24e-05	0.000307	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2—brain cancer	3.21e-05	0.000304	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APC—brain cancer	3.2e-05	0.000303	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CG—brain cancer	3.2e-05	0.000303	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PDGFRA—brain cancer	3.15e-05	0.000299	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2—brain cancer	3.14e-05	0.000297	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PDGFRA—brain cancer	3.09e-05	0.000292	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SPP1—brain cancer	3.06e-05	0.00029	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SPP1—brain cancer	3e-05	0.000284	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2—brain cancer	2.91e-05	0.000276	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EGFR—brain cancer	2.91e-05	0.000276	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2—brain cancer	2.85e-05	0.00027	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IRS2—brain cancer	2.77e-05	0.000262	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IRS2—brain cancer	2.71e-05	0.000257	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RELA—brain cancer	2.5e-05	0.000237	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ERBB2—brain cancer	2.48e-05	0.000235	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CG—brain cancer	2.45e-05	0.000232	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APC—brain cancer	2.45e-05	0.000232	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APC—brain cancer	2.39e-05	0.000227	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CG—brain cancer	2.39e-05	0.000227	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2—brain cancer	2.25e-05	0.000213	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EGFR—brain cancer	2.23e-05	0.000211	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCND1—brain cancer	2.19e-05	0.000208	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EGFR—brain cancer	2.18e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CTNNB1—brain cancer	2.17e-05	0.000206	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—brain cancer	1.91e-05	0.000181	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RELA—brain cancer	1.91e-05	0.000181	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ERBB2—brain cancer	1.9e-05	0.00018	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT3—brain cancer	1.89e-05	0.000179	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RELA—brain cancer	1.87e-05	0.000177	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ERBB2—brain cancer	1.86e-05	0.000176	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MYC—brain cancer	1.76e-05	0.000167	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2—brain cancer	1.72e-05	0.000163	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EGFR—brain cancer	1.72e-05	0.000163	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CG—brain cancer	1.71e-05	0.000162	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2—brain cancer	1.68e-05	0.00016	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCND1—brain cancer	1.68e-05	0.000159	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.66e-05	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCND1—brain cancer	1.64e-05	0.000156	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CTNNB1—brain cancer	1.63e-05	0.000154	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—brain cancer	1.46e-05	0.000139	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT3—brain cancer	1.45e-05	0.000137	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—brain cancer	1.44e-05	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—brain cancer	1.43e-05	0.000136	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT3—brain cancer	1.42e-05	0.000134	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MYC—brain cancer	1.35e-05	0.000127	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MYC—brain cancer	1.32e-05	0.000125	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EGFR—brain cancer	1.32e-05	0.000125	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EGFR—brain cancer	1.29e-05	0.000122	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—brain cancer	1.11e-05	0.000105	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—brain cancer	1.08e-05	0.000102	CbGpPWpGaD
